2 - Network organisation and process
Quality
Management |
Training and
Education |
Public
Involvement |
Description | ||
---|---|---|
Name |
EUNETHYDIS - European Network for Hyperkinetic Disorders |
|
Existence of an identified contact person for external enquiries | Yes | Prof. Dr J.A.Sergeant |
Existence of an internal steering committee | Yes | Internal steering committee: Prof. J. Sergeant, Dr. D. Coghill, Prof. T. Banaschewski, Prof. E. Sonuga-Barke, Prof. M. Holtmann, Dr. S. Cortese, Prof Chris Hollis, Prof Emily Simonoff |
Existence of an external advisory steering committee directing the reporting party | No | |
Existence of a website | No | Under Construction |
Existence of newsletter | No | All network communications are published in scientific journals. |
Existence of internal databases for disease, condition treatment and/or outcome | No | Due to privacy issues internal data bases/disease registries are located at each of the participating clinics. There are also cross site databases of of genetic data that have arisen as a consequence of specific projects. Through Prof. I. Wong the network has access to a range of pharmacoepidemiological databases and through extrenal collaborations we are able to access to several other large long term prospective databases as required for specific projects. |
Provisions to ascertain data protection and data security | Yes | All databases comply with national and international standards for data protection. |
Procedures to access the database by third parties | Yes | All database comply with national and international standards for allowing access to third parties as appropriate. |
Access to external databases/registries | Yes | As noted in 2.6, members of the network have, through their research collaborations, privileged access to a broad range of large research databases not usually accessible to the public. In addition, the network has access to several large national and international pharmacoepidemiological and pharmacovigilence databases. The Network is in discussion with the EMA to be a pilot site for accessing their pharmacovigilence database. In addition we have a long history of collaborative work with industry partners which includes participation in data mining panels and assisting with the design and implementation of data mining projects of large clinical trials datasets. |
Standardised process to access an external database | Yes | Due to the wide range of databases used in various projects and the very different requirements set out by the owners of these data these are negotiated and defined as required. |